Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
about
Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5.Down-regulation of MyoD by calpain 3 promotes generation of reserve cells in C2C12 myoblastsInhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivoThe Carboxy-Terminal Modulator Protein (CTMP) regulates mitochondrial dynamicsp38-{gamma}-dependent gene silencing restricts entry into the myogenic differentiation program.Conditional transgenic system for mouse aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein.Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis.Conditional TGF-β1 treatment increases stem cell-like cell population in myoblasts.Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability.Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transitionChromatin modification and muscle differentiation.Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD proteinMyoD phosphorylation on multiple C terminal sites regulates myogenic conversion activity.Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics.iPTMnet: an integrated resource for protein post-translational modification network discovery.
P2860
Q24814111-AE98A7F9-0482-4FC3-8053-FC5E25F78041Q28512068-02AF0D21-74AE-46D3-8551-69DD21842ED7Q28512771-51D3F69D-2BB5-4772-8E0D-D8B85E7E694FQ33440639-A96F2FA2-607B-4927-8EA6-1F74408C5BB0Q33589771-9E8B0C2F-84C7-4FEF-981B-8DD0C56C0A73Q33836953-4E683C50-A5CA-45ED-8D6D-844E5D6DF583Q33950260-B25D3272-D46C-483B-AC1B-45E85CEBED74Q34433454-71F06F6B-9113-4C66-B134-6D89A2454CD1Q35102090-7177925C-3463-4D41-BF6C-1B7CF212A289Q36189301-E63CC6C3-9059-4059-8D11-EE13F6ADBCDBQ36653676-D87614DA-1F5E-4D71-9731-847D4DF8875EQ36739956-344AEDB8-00AA-4530-AFA6-0B59830B0C98Q38732371-455F4FB0-C199-444A-BA45-52703B4F1B58Q38805063-FF04E63D-AF37-4DB6-A17D-23839B4D0FC1Q46260198-E3E94C21-C0A2-4DAD-B4F6-0DD76E6F7EBB
P2860
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
@ast
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
@en
type
label
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
@ast
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
@en
prefLabel
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
@ast
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
@en
P2093
P2860
P1476
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
@en
P2093
Didier Metivier
Lionel A J Tintignac
Maria Castedo
Marie Pierre Leibovitch
Serge A Leibovitch
Valentina Sirri
Yann Lécluse
P2860
P304
P356
10.1128/MCB.24.4.1809-1821.2004
P407
P577
2004-02-01T00:00:00Z